Adam Octavian R, Jankovic Joseph
Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
Parkinsonism Relat Disord. 2007;13 Suppl 3:S362-8. doi: 10.1016/S1353-8020(08)70031-2.
Dystonia varies in severity from simple focal dystonia, such as writer's cramp to life-threatening status dystonicus. Even though the pathophysiology is still elusive, symptomatic treatments may provide marked relief. Botulinum toxin is considered the treatment of choice for most focal and segmental dystonias. Deep brain stimulation of the basal ganglia, particularly the globus pallidus internum, is emerging as an important treatment for refractory, generalized, and segmental forms of dystonia. Gene therapy is also being explored as a possible treatment of inherited dystonias. This article reviews the therapeutic options available for the various types of dystonia.
肌张力障碍的严重程度各异,从简单的局灶性肌张力障碍,如书写痉挛,到危及生命的张力障碍危象。尽管其病理生理学仍不明确,但对症治疗可能会带来显著缓解。肉毒杆菌毒素被认为是大多数局灶性和节段性肌张力障碍的首选治疗方法。对基底神经节,尤其是内侧苍白球进行深部脑刺激,正成为治疗难治性、全身性和节段性肌张力障碍的一种重要方法。基因治疗也正在被探索作为遗传性肌张力障碍的一种可能治疗方法。本文综述了针对各种类型肌张力障碍的可用治疗选择。